SCHEMBL20043032

SCHEMBL20043032

CN(C)C1=C(Br)C(=O)c2ccccc2C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.55
AURKB Q96GD4 1/20 0.55
ALDH1A1 P00352 7/20 0.50
MAPT P10636 6/20 0.50
RAB9A P51151 4/20 0.50
POLB P06746 3/20 0.50
NSD2 O96028 2/20 0.50
NPC1 O15118 2/20 0.50
HKDC1 Q2TB90 1/20 0.47
MALT1 Q9UDY8 1/20 0.46
LMNA P02545 3/20 0.44
MAPK1 P28482 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
EGFR P00533 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
CDC25B P30305 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31171425 0.84 MEN1 (0.55) ALDH1A1MAPTRAB9APOLBNSD2
SCHEMBL29967684 0.80 HKDC1 (0.51) ALDH1A1MAPTRAB9APOLBNSD2
SCHEMBL10615443 0.79 AURKA (0.50) AURKAAURKBALDH1A1MAPTRAB9A
SCHEMBL20046959 0.78 HKDC1 (0.50) ALDH1A1MAPTRAB9APOLBNSD2
SCHEMBL868107 0.77 MAOA (0.56) AURKAAURKBALDH1A1MAPTPOLB
2,3-Dibromo-1,4-Naphthoquinone SCHEMBL1240837 0.77 MAPT (0.68) AURKAAURKBALDH1A1MAPTRAB9A
2,3-Dibromo-1,4-Naphthoquinone SCHEMBL29475349 0.77 MAPT (0.68) AURKAAURKBALDH1A1MAPTRAB9A
SCHEMBL31290114 0.75 IDO1 (0.60) ALDH1A1MAPTRAB9APOLBNSD2
SCHEMBL2462086 0.75 IDO1 (0.60) ALDH1A1MAPTRAB9APOLBNSD2
Anthraquinone SCHEMBL27847594 0.71 CDC25B (0.75) ALDH1A1MAPTRAB9APOLBNSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118932351-A Electrochemical tandem preparation and application of antibacterial compound 2-amino quinone 温州医科大学附属口腔医院 2024-11-12 CN disclosed
US-20180099917-A1 REVERSIBLY REDUCIBLE MATERIALS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180099917-A1 REVERSIBLY REDUCIBLE MATERIALS AND USE THEREOF NES, CBR3, SQOR AURKA 1212/4885AURKB 1867/4885ALDH1A1 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.